TECHNICAL BULLETINS

Technical Bulletin - Antibacterial Wipes (44 KB): Virox Technologies Inc.
Excerpt:“As Gareth Williams the lead researcher for the study stated “We found the most effective way to prevent the risk of MRSA spread in hospital wards is to ensure the wipe is used only once on one surface”. This should not come as a shock to anyone. Best practices for infection control recommend exactly this and this is how we train our Environmental Services staff, we just need to ensure that all staff within the healthcare facility understands how to appropriately use antimicrobial wipes.” pg. 2
The Importance of Contact Times for Disinfectants (118 KB): Virox Technologies Inc.
Excerpt:“Accelerated Hydrogen Peroxide was the only chemistry that was able to achieve disinfection using the drying time regardless of contact time.”
Technical Bulletin - Calculating Product Concentrations (41 KB): Virox Technologies Inc.
To ensure optimal cleaning or disinfection it is important that products are used at the dilution ratio specified on the product label. From time to time Public Health or Infection Control may request that the dilution control systems be tested to confirm the products are being diluted appropriately so it is important to know how to calculate Use Dilution concentration.
Technical Bulletin on pH (212 KB): Virox Technologies Inc.
Excerpt:“pH is not the sole factor in determining the irritation/toxicity of a product. Each raw material by itself can contribute in the toxicity and irritation of the formula as a whole. The easiest way for your customers to find out about the toxicity/irritation of a product is to look into the toxicity/irritation tests for that product and they should make sure those tests have been 3rd party validated. ”
Technical Bulletin - Clostridium Difficile (136 KB): Virox Technologies Inc.
Clostridium difficile is an increasingly common nosocomial pathogen whose spores are very resistant to disinfectants. Many facilities in North America have experienced or are experiencing difficulties in combating Clostridium difficile and are not exactly sure as to what cleaners and/or disinfectants should be used.
Excerpt:“In Canada, a 4.5% Accelerated Hydrogen Peroxide formula has received DIN registration as the first and only DIN registered Environmental Surface Sporicidal Agent with efficacy specifically against C. difficile. The formulation is available as a Gel, Liquid and Pre-moistened Wipes.”
Technical Bulletin - Avian Influenza (154 KB): Virox Technologies Inc.
Excerpt:“When looking for confidence in efficacy against potential Avian Flu viruses’ known and unknown, Health Canada registered products with a General Virucide Claim and a Broad Spectrum Bactericidal and Sanitizing Claim (gram-positive and gram-negative bacteria) in short contact times would be ideal. ”
Technical Bulletin on Hepatitis B and Hepatitis C (127 KB): Virox Technologies Inc.
This document will help you and decision makers to better understand which label claims are relevant and those that are not.
Technical Bulletin - PIDAC Guidelines (117 KB): Virox Technologies Inc.
Excerpt:“AHP has gained a reputation for being the most effective and safest disinfection product on the market. The addition of AHP into this document provides support that can help to convert healthcare facilities to AHP that are currently using quats, phenols, orthophthaladehyde or glutaraldehydes. ”
Technical Bulletin - Biofilm (129 KB): Virox Technologies Inc.
This document will help you and decision makers to better understand what Biofilms are and the relevance of using a disinfectant capable of killing and removing them.
Technical Bulletin – Staphylococcus aureus: HA-MRSA & CA-MRSA (126 KB): Virox Technologies Inc.
This document will help you and decision makers to better understand the basic infection control principles of controlling the transmission of HA-MRSA in healthcare settings and CA-MRSA in community settings.
Technical Bulletin – Vancomycin-Resistant Enterococci: VRE (122 KB): Virox Technologies Inc.
This document will help you and decision makers to better understand the basic infection control principles of controlling the transmission of VRE in healthcare settings.
Technical Bulletin – Public Health Pests: Scabies, Lice & Bed Bugs (129 KB): Virox Technologies Inc.
This document will help you and decision makers to better understand the basic infection control principles of controlling the transmission of Public Health Pests such as Scabies, Lice and Bed Bugs in both healthcare settings and community settings.
Technical Bulletin - Canadian American Business Achievement Award (98 KB): Virox Technologies Inc.
Excerpt:“As a result of Virox’s partnership with JohnsonDiversey we are very excited to announce that both Virox and JohnsonDiversey have been awarded the prestigious Canadian American Business Achievement Award. This award is bestowed to a Canadian and American company whose joint enterprise demonstrates both the business and trade relationship between the United States and Canada. An international panel of judges using a criterion that examines sustained profitability, job creation, financial strength, environmental responsibility, corporate synergy, exceptional imagination and extraordinary innovation chooses the recipients. ”
Technical Bulletin - Airborne Transmitted Diseases (159 KB): Virox Technologies Inc.
Excerpt:“With the media publishing more and more reports on Tuberculosis and other airborne diseases, what is their relevance in terms of environmental surface cleaning and disinfection? This document will help you to better understand the basic infection control principles of controlling the transmission of Airborne Transmitted Diseases such as Tuberculosis, Chickenpox, and Measles. ”
Technical Bulletin - Canadian Government to Ban or Restrict Toxic Chemicals (126 KB): Virox Technologies Inc.
Excerpt:“With the introduction of Canada’s stronger stance on chemicals, Health Care facilities that are currently using quats, phenols, ortho-phthaladehyde or glutaraldehydes will be reviewing the chemicals they use and looking for safer and sustainable alternatives. The proven health and safety profile of AHP and SHP solutions will make these products a perfect alternative. ”
Technical Bulletin on a Toronto C. diff Outbreak (189 KB): Virox Technologies Inc.
Excerpt:“AHP has gained a reputation for being the most effective and safest disinfection product on the market. The use of AHP at Toronto East General Hospital to help in the management of C. difficile is an excellent example to have in your arsenal of support for the use of AHP. ”
Technical Bulletin on ChildSafe Guidelines (96 KB): Virox Technologies Inc.
Excerpt:“Based on the research and subsequent testing that has been conducted on the final AHP and SHP products Virox has demonstrated that when compared to other products on the market, AHP and SHP are some of the safest to be found. With the movement towards using products that are safer for staff, and students in schools and daycare facilities, the proven health and safety profile of AHP and SHP solutions will make these products a perfect alternative. ”
Technical Bulletin on Chlorine and Chlorine Compounds: Why is Bleach Used? (131 KB): Virox Technologies Inc.
This document will provide a background on the use of chlorine and chlorine compounds, their history in healthcare and some limiting factors to the use of bleach as a disinfectant. Additionally, this document will address the potential concerns surrounding the introduction of new bleach-based products that have not gone through the Health Canada DIN registration process and therefore, provide limited to no support data with respect to disinfection contact times.
Technical Bulletin in Response to Occupational Health & Safety Agency for Healthcare in British Columbia (130 KB): Virox Technologies Inc.
Excerpt:“As is clearly implied in the release, it is without a doubt best practice to not mix chemicals of any sort whether at home or at work. This is especially true with Chlorine based compounds such as bleach and highlights one of the reasons fewer and fewer facilities use bleach. Regardless of chemistry, whenever chemicals can be standardized including cleaning products and disinfectant products it is preferable as this reduces the potential risk for adverse outcomes.”
Technical Bulletin on EcoLogo Disinfectant-Cleaner Registration of Accelerated Hydrogen Peroxide (195 KB): Virox Technologies Inc.
Excerpt:“Accelerated Hydrogen Peroxide has proven its superiority with respect to cleaning and disinfection properties and can now proudly display the EcoLogo as Canada’s FIRST registered Disinfectant-Cleaner. ”
Technical Bulletin on the Effects of an Environmental Services Professional Training Course and Cleaning Products on the Rates of Infection Seen at Suburban Hospital (145 KB): Virox Technologies Inc.
Excerpt:“The purpose of this study was to evaluate the effectiveness of a formal, eight-hour training course for hospital environmental services personnel on the overall rate of infections seen in a mid-sized suburban hospital. ”
Technical Bulletin on The Oxivir Tb Formulation of Accelerated Hydrogen Peroxide (AHP) is effective for Killing Clostridium difficile Spores on Toilet Seat Surfaces (134 KB): Virox Technologies Inc.
Excerpt:“The evidence from this study shows that the Oxivir Tb formulation is a useful alternative to bleach for surface killing of C. difficile spores.”
Technical Bulletin on the Best Practices Document for Management of Clostridium difficile in all health care settings (135 KB): Virox Technologies Inc.
This document deals with the prevention and control of the transmission of Clostridium difficile Associated Disease (CDAD) in acute and non-acute health care settings and sets out the infection prevention and control practices to focus on preventing the transmission of CDAD to other patients, assist health care providers to promptly identify clusters of CDAD as well as to assist health care providers in the management of patients with CDAD and outbreaks related to CDAD.
Technical Bulletin on Extended‐Spectrum Beta (β) Lactamases (ESBLs) (294 KB): Virox Technologies Inc.
Excerpt:“AHP at 0.5% carries a 30-second broad-spectrum sanitizing claim and a disinfection contact time of 1 – 5 minutes depending on formulation against ESBL producing bacteria such as Salmonella, Pseudomonas, E. Coli and Klebsiella. ”
Technical Bulletin on Serratia marcescens (276 KB): Virox Technologies Inc.
Excerpt:“AHP at 0.5% carries a 30-second broad-spectrum sanitizing claim and a disinfection contact time of 1 – 5 minutes depending on formulation against gram negative bacteria such as S. marcescens. ”
Technical Bulletin on Acinetobacter baumannii (285 KB): Virox Technologies Inc.
Excerpt:“AHP at 0.5% carries a 30-second broad-spectrum sanitizing claim against A. Baumannii and a disinfection contact time of 1 – 5 minutes depending on formulation. ”
Technical Bulletin on Mumps (261 KB): Virox Technologies Inc.
Excerpt:“AHP at 0.5% carries a 30-second broad-spectrum sanitizing claim and a disinfection contact time of 1 – 5 minutes depending on formulation against both nonenveloped and enveloped viruses such as the mumps virus. ”
Technical Bulletin on Compatibility (177 KB): Virox Technologies Inc.
Excerpt:“The Reality: One product for all surfaces and devices does not exist. No disinfectant chemistry is compatible with 100% of all surfaces or devices. ”
Technical Bulletin on MRSA in EMS Vehicles (171 KB): Virox Technologies Inc.
Excerpt:“AHP is a very good cleaner as well as an effective disinfectant that carries a 30-second Broad-Spectrum Sanitizing claim which provides a 5-Log reduction (99.999% kill) against MRSA. This means that in 30-seconds the surface has been rendered safe to use. ”